Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 4
2020 5
2021 2
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean marcel gehring (1 results)?
ZMIZ1 enhances ERα-dependent expression of E2F2 in breast cancer.
Zhao W, Rose SF, Blake R, Godicelj A, Cullen AE, Stenning J, Beevors L, Gehrung M, Kumar S, Kishore K, Sawle A, Eldridge M, Giorgi FM, Bridge KS, Markowetz F, Holding AN. Zhao W, et al. Among authors: gehrung m. J Mol Endocrinol. 2024 Apr 25;73(1):e230133. doi: 10.1530/JME-23-0133. Print 2024 Jul 1. J Mol Endocrinol. 2024. PMID: 38564418
Lesion-specific 3D-printed moulds for image-guided tissue multi-sampling of ovarian tumours: A prospective pilot study.
Delgado-Ortet M, Reinius MAV, McCague C, Bura V, Woitek R, Rundo L, Gill AB, Gehrung M, Ursprung S, Bolton H, Haldar K, Pathiraja P, Brenton JD, Crispin-Ortuzar M, Jimenez-Linan M, Escudero Sanchez L, Sala E. Delgado-Ortet M, et al. Among authors: gehrung m. Front Oncol. 2023 Feb 13;13:1085874. doi: 10.3389/fonc.2023.1085874. eCollection 2023. Front Oncol. 2023. PMID: 36860310 Free PMC article.
Hyperpolarized 13C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma-A Proof of Principle Study.
Ursprung S, Woitek R, McLean MA, Priest AN, Crispin-Ortuzar M, Brodie CR, Gill AB, Gehrung M, Beer L, Riddick ACP, Field-Rayner J, Grist JT, Deen SS, Riemer F, Kaggie JD, Zaccagna F, Duarte JAG, Locke MJ, Frary A, Aho TF, Armitage JN, Casey R, Mendichovszky IA, Welsh SJ, Barrett T, Graves MJ, Eisen T, Mitchell TJ, Warren AY, Brindle KM, Sala E, Stewart GD, Gallagher FA. Ursprung S, et al. Among authors: gehrung m. Cancers (Basel). 2022 Jan 11;14(2):335. doi: 10.3390/cancers14020335. Cancers (Basel). 2022. PMID: 35053497 Free PMC article.
Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
Fitzgerald RC, di Pietro M, O'Donovan M, Maroni R, Muldrew B, Debiram-Beecham I, Gehrung M, Offman J, Tripathi M, Smith SG, Aigret B, Walter FM, Rubin G; BEST3 Trial team; Sasieni P. Fitzgerald RC, et al. Among authors: gehrung m. Lancet. 2020 Aug 1;396(10247):333-344. doi: 10.1016/S0140-6736(20)31099-0. Lancet. 2020. PMID: 32738955 Free PMC article. Clinical Trial.
17 results